<DOC>
	<DOCNO>NCT01041885</DOCNO>
	<brief_summary>The purpose study investigate whether INSTRUCT therapy safe effective treatment cartilage defect knee .</brief_summary>
	<brief_title>INSTRUCT Repair Knee Cartilage Defects</brief_title>
	<detailed_description>This prospective , open-label , single-arm pilot study design investigate safety efficacy INSTRUCT therapy treatment knee cartilage defect . All patient meet eligibility criterion consent participate undergo implantation biodegradable scaffold seed autologous primary chondrocytes bone marrow cell via arthrotomy . Patients followed-up 2 year regular interval . Evaluations include adverse event collection , patient report outcome ( mostly pain function ) , arthroscopic histologic evaluation MRIs ( include dGEMRIC ) .</detailed_description>
	<criteria>Patients symptomatic articular cartilage defect knee Surgery study knee joint within 6 month Patients significant malalignment ( 5Â° ) Patients ligamentous instability knee Majority meniscus absent Severe osteoarthritis Intake medication treatment effect bone cartilage formation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>knee cartilage defect repair</keyword>
	<keyword>cartilage lesion</keyword>
	<keyword>autologous chondrocyte</keyword>
	<keyword>scaffold</keyword>
	<keyword>INSTRUCT</keyword>
</DOC>